NCT00102544 2026-03-06Use of Tracking Devices to Locate Abnormalities During Invasive ProceduresNational Institutes of Health Clinical Center (CC)Phase NA Enrolling by invitation3,894 enrolled
NCT04895748 2026-03-03DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other MalignanciesNovartisPhase 1 Terminated40 enrolled